INTRODUCTION AND OBJECTIVES: Few studies in Spain have reported the distribution of metabolic syndrome using the harmonized definition and that of premorbid metabolic syndrome, which consists of metabolic syndrome without diabetes mellitus or cardiovascular disease. Moreover, their regional distributions and clinical management are unknown. The present study examined the distributions and clinical management of both syndromes in Spain. METHODS: This cross-sectional study was performed from 2008 to 2010 in 11 149 representative individuals of the Spanish population aged 18 years or older. Data were obtained through standardized physical examination, and analytical measurements were done in a central laboratory. RESULTS: The prevalences (95% confidence interval) of metabolic syndrome and premorbid metabolic syndrome were 22.7% (21.7%-23.7%) and 16.9% (16.0%-17.8%), respectively. The frequency of both syndromes increased with age and was higher in men than in women up to 65 years; above this age, the frequency was higher in women. The communities of the south of Spain and the Balearic and Canary islands had the highest prevalence of both syndromes, in some regions reaching double that of the community with the lowest prevalence. About one third of patients with premorbid metabolic syndrome reported that they had not received health recommendations to improve their lifestyles; of those that did receive advice, adherence was low, particularly for reducing weight (31.9%) and salt intake (38.3%). CONCLUSIONS: The prevalence of metabolic syndrome is high in Spain and considerable geographical differences exist in its distribution. There is substantial room for improvement in the clinical management of premorbid metabolic syndrome.
INTRODUCTION AND OBJECTIVES: Few studies in Spain have reported the distribution of metabolic syndrome using the harmonized definition and that of premorbid metabolic syndrome, which consists of metabolic syndrome without diabetes mellitus or cardiovascular disease. Moreover, their regional distributions and clinical management are unknown. The present study examined the distributions and clinical management of both syndromes in Spain. METHODS: This cross-sectional study was performed from 2008 to 2010 in 11 149 representative individuals of the Spanish population aged 18 years or older. Data were obtained through standardized physical examination, and analytical measurements were done in a central laboratory. RESULTS: The prevalences (95% confidence interval) of metabolic syndrome and premorbid metabolic syndrome were 22.7% (21.7%-23.7%) and 16.9% (16.0%-17.8%), respectively. The frequency of both syndromes increased with age and was higher in men than in women up to 65 years; above this age, the frequency was higher in women. The communities of the south of Spain and the Balearic and Canary islands had the highest prevalence of both syndromes, in some regions reaching double that of the community with the lowest prevalence. About one third of patients with premorbid metabolic syndrome reported that they had not received health recommendations to improve their lifestyles; of those that did receive advice, adherence was low, particularly for reducing weight (31.9%) and salt intake (38.3%). CONCLUSIONS: The prevalence of metabolic syndrome is high in Spain and considerable geographical differences exist in its distribution. There is substantial room for improvement in the clinical management of premorbid metabolic syndrome.
Authors: Ismael Alvarez-Alvarez; Estefanía Toledo; Oscar Lecea; Jordi Salas-Salvadó; Dolores Corella; Pilar Buil-Cosiales; María Dolores Zomeño; Jesús Vioque; J Alfredo Martinez; Jadwiga Konieczna; Francisco J Barón-López; José López-Miranda; Ramon Estruch; Aurora Bueno-Cavanillas; Ángel M Alonso-Gómez; Josep A Tur; Francisco J Tinahones; Lluís Serra-Majem; Vicente Martín; Manuel Ortega-Calvo; Clotilde Vázquez; Xavier Pintó; Josep Vidal; Lidia Daimiel; Miguel Delgado-Rodríguez; Pilar Matía; José I González; Andrés Díaz-López; Indira Paz-Graniel; Miguel A Muñoz; Montse Fito; Salvador Pertusa-Martinez; Itziar Abete; Antonio García-Ríos; Emilio Ros; Miguel Ruiz-Canela; Miguel Á Martínez-González Journal: Eur J Nutr Date: 2019-05-09 Impact factor: 5.614
Authors: Enrique Regidor; Laura Reques; Carolina Giráldez-García; Estrella Miqueleiz; Juana M Santos; David Martínez; Luis de la Fuente Journal: PLoS One Date: 2015-07-24 Impact factor: 3.240
Authors: Itziar Lamiquiz-Moneo; Cristian Blanco-Torrecilla; Ana M Bea; Rocío Mateo-Gallego; Sofía Pérez-Calahorra; Lucía Baila-Rueda; Ana Cenarro; Fernando Civeira; Isabel de Castro-Orós Journal: Lipids Health Dis Date: 2016-04-23 Impact factor: 3.876
Authors: Vannina G Marrachelli; Pilar Rentero; María L Mansego; Jose Manuel Morales; Inma Galan; Mercedes Pardo-Tendero; Fernando Martinez; Juan Carlos Martin-Escudero; Laisa Briongos; Felipe Javier Chaves; Josep Redon; Daniel Monleon Journal: PLoS One Date: 2016-09-02 Impact factor: 3.240